On the role of dendritic cells versus other cells in inducing protective CD8+ T cell responses

Frontiers in Immunology

Volumn 5, Issue FEB, 2014, Pages

  Zinkernagel, Rolf Martin ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

Crosspresentation; Fibroblast APCs; Lymphnode; Tolerance; Tumor immunity

Indexed keywords

FIBRIN;

CD8+ T LYMPHOCYTE; CELL TRANSPLANTATION; DENDRITIC CELL; ENDOPLASMIC RETICULUM; FIBROBLAST; IMMUNE RESPONSE; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NOTE; SKIN GRAFT; TUMOR CELL;

EID: 84895516865     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00030     Document Type: Note

References (12)

1. Banchereau J, Steinman RM. Dendritic cells and the control of antigen immunity. Nature (1998) 392:245-52. doi:10.1038/32588.
2. Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM. Dendritic cells induce autoimmune diabetes and maintain disease via De novo formation of local lymphoid tissue. J Exp Med (1998) 188:1493-501. doi:10.1084/jem.188.8.1493.
3. Ludewig B, Maloy KJ, Lopez-Macias C, Odermatt B, Hengartner H, Zinkernagel RM. Induction of optimal anti-viral neutralizing B cell responses by dendritic cells requires transport and release of virus particles in secondary lymphoid organs. Eur J Immunol (2000) 30:185-96. doi:10.1002/1521-4141(200001)30:1<::AID-IMMU185>3.0.CO;2-L.
4. Ludewig B, Ochsenbein AF, Odermatt B, Paulin D, Hengartner H, Zinkernagel RM. Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med (2000) 191:795-804. doi:10.1084/jem.191.5.795.
5. Kündig TM, Bachmann MF, DiPaolo C, Simard JJ, Battegay M, Lother H, et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science (1995) 268:1343-7. doi:10.1126/science.7761853.
6. Zinkernagel RM. On cross-priming of MHC class I-specific CTL: rule or exception? Eur J Immunol (2002) 32:2385-92. doi:10.1002/1521-4141(200209)32:9<::AID-IMMU2385>3.0.CO;2-V.
7. Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U, Hermans J, et al. Roles of tumour localization, second signals and cross priming in cytotoxic T cell induction. Nature (2001) 411:1058-64. doi:10.1038/35082583.
8. Freigang S, Egger D, Bienz K, Hengartner H, Zinkernagel RM. Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming. Proc Natl Acad Sci U S A (2003) 100:13477-82. doi:10.1073/pnas.1835685100.
9. Freigang S, Eschli B, Harris N, Geuking M, Quirin K, Schrempf S, et al. A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8(+) T cell responses. Proc Natl Acad Sci U S A (2007) 104:13426-31. doi:10.1073/pnas.0704423104.
10. Pericin M, Althage A, Freigang S, Hengartner H, Rolland E, Dupraz P, et al. Allogeneic beta-islet cells correct diabetes and resist immune rejection. Proc Natl Acad Sci U S A (2002) 99:8203-6. doi:10.1073/pnas.122241299.
11. Ohashi PS, Oehen S, Buerki K, Pircher HP, Ohashi CT, Odermatt B, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell (1991) 65:305-17. doi:10.1016/0092-8674(91)90164-T.
12. Ochsenbein AF, Klenerman P, Karrer U, Ludewig B, Pericin M, Hengartner H, et al. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A (1999) 96:2233-8. doi:10.1073/pnas.96.5.2233.